According to Zhifei Biotech, recently, Liraglutide injection independently developed and produced by Chongqing Chen'an Biopharmaceutical Co., Ltd., a subsidiary of Zhifei Biotech Holdings, completed the first injection in the country at Banan Hospital affiliated to Chongqing Medical University. The clinical application of liraglutide injection Dashuchen® provides a new domestically produced medication option for standardized treatment of diabetics.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.